pharmaceutical investing RedHill Biopharma Announces Completion of Enrollment for Confirmatory Phase III Study with TALICIA for H. pylori Infection
RedHill Biopharma Receives Allowance for New U.S. Patent Covering RHB-106, an Encapsulated Bowel Preparation
pharmaceutical investing RedHill Biopharma Initiates Co-Promotion of HIV/AIDS Anti-Diarrheal Drug Mytesi®
Sitka Drills 119.0 Metres of 1.01 g/t Gold from Surface, Including 10.7 Metres of 4.10 g/t Gold and 1.2 Metres of 24.8 g/t Gold, at the Contact Zone, Confirming Another near Surface Higher-Grade Gold Zone at Its RC Gold Project, Yukon
